Analystreport

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.

Bellicum Pharmaceuticals, Inc.  (BLCM) 
Last bellicum pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bellicum.com/investor-overview